CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 168 filers reported holding CLOVIS ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is 1.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $3,000 | -25.0% | 600 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $4,000 | +33.3% | 600 | 0.0% | 0.00% | +100.0% |
| Q4 2020 | $3,000 | 0.0% | 600 | 0.0% | 0.00% | -50.0% |
| Q3 2020 | $3,000 | -25.0% | 600 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $4,000 | 0.0% | 600 | 0.0% | 0.00% | -33.3% |
| Q1 2020 | $4,000 | -33.3% | 600 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $6,000 | +200.0% | 600 | 0.0% | 0.00% | +200.0% |
| Q3 2019 | $2,000 | -77.8% | 600 | 0.0% | 0.00% | -75.0% |
| Q2 2019 | $9,000 | -40.0% | 600 | 0.0% | 0.00% | -33.3% |
| Q1 2019 | $15,000 | +36.4% | 600 | 0.0% | 0.01% | +20.0% |
| Q4 2018 | $11,000 | -8.3% | 600 | +50.0% | 0.01% | +25.0% |
| Q3 2018 | $12,000 | -33.3% | 400 | 0.0% | 0.00% | -42.9% |
| Q2 2018 | $18,000 | -14.3% | 400 | 0.0% | 0.01% | +16.7% |
| Q1 2018 | $21,000 | -22.2% | 400 | 0.0% | 0.01% | -25.0% |
| Q4 2017 | $27,000 | +8.0% | 400 | +33.3% | 0.01% | 0.0% |
| Q3 2017 | $25,000 | – | 300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |